ATE358719T1 - Hefebehandlung - Google Patents
HefebehandlungInfo
- Publication number
- ATE358719T1 ATE358719T1 AT03812529T AT03812529T ATE358719T1 AT E358719 T1 ATE358719 T1 AT E358719T1 AT 03812529 T AT03812529 T AT 03812529T AT 03812529 T AT03812529 T AT 03812529T AT E358719 T1 ATE358719 T1 AT E358719T1
- Authority
- AT
- Austria
- Prior art keywords
- liposome
- molar
- lipid bilayer
- yeast treatment
- liposome lipid
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 239000002502 liposome Substances 0.000 abstract 6
- 239000000232 Lipid Bilayer Substances 0.000 abstract 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 abstract 2
- MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 150000008104 phosphatidylethanolamines Chemical group 0.000 abstract 2
- 229930182558 Sterol Natural products 0.000 abstract 1
- KLHSDMQFUVANEB-MELZOAELSA-L hexadecyl-[(2r,3r)-4-[hexadecyl(dimethyl)azaniumyl]-2,3-dimethoxybutyl]-dimethylazanium;dibromide Chemical group [Br-].[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C[C@@H](OC)[C@H](OC)C[N+](C)(C)CCCCCCCCCCCCCCCC KLHSDMQFUVANEB-MELZOAELSA-L 0.000 abstract 1
- 125000002328 sterol group Chemical group 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002953285A AU2002953285A0 (en) | 2002-12-12 | 2002-12-12 | Yeast treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358719T1 true ATE358719T1 (de) | 2007-04-15 |
Family
ID=30004370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03812529T ATE358719T1 (de) | 2002-12-12 | 2003-12-04 | Hefebehandlung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040147028A1 (de) |
| EP (1) | EP1573001B1 (de) |
| JP (1) | JP2006509501A (de) |
| AT (1) | ATE358719T1 (de) |
| AU (1) | AU2002953285A0 (de) |
| DE (1) | DE60313031T2 (de) |
| ES (1) | ES2285271T3 (de) |
| NZ (1) | NZ541173A (de) |
| WO (1) | WO2004053118A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1824453A4 (de) * | 2004-12-16 | 2010-08-18 | Protech Res Pty Ltd | Transfer von molekülen |
| JP4900718B2 (ja) * | 2005-06-09 | 2012-03-21 | 独立行政法人産業技術総合研究所 | 分泌型発光酵素を用いたレポーターアッセイ |
| WO2007031333A2 (en) * | 2005-09-15 | 2007-03-22 | Novosom Ag | Improvements in or relating to amphoteric liposomes |
| JP5325576B2 (ja) * | 2006-06-30 | 2013-10-23 | 北海道システム・サイエンス株式会社 | 核酸導入用組成物 |
| EP2440181A2 (de) * | 2009-06-08 | 2012-04-18 | Epitarget AS | Akustisch sensitive wirkstofffreisetzungspartikel mit phosphatidylethanolamin |
| WO2010143971A2 (en) * | 2009-06-08 | 2010-12-16 | Epitarget As | Lipophilic drug carrier |
| WO2010143972A2 (en) * | 2009-06-08 | 2010-12-16 | Epitarget As | Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids |
| TR201906107T4 (tr) * | 2011-05-20 | 2019-05-21 | Merck Patent Gmbh | Dotap klorürün stabil kristal modifikasyonlarının hazırlanması. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4789633A (en) * | 1984-04-19 | 1988-12-06 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
| JPS62201595A (ja) * | 1986-01-29 | 1987-09-05 | Sanyo Kokusaku Pulp Co Ltd | 酵母エキスの製造法 |
| US5698721A (en) * | 1992-12-17 | 1997-12-16 | Megabios Corporation | Catonic amphiphiles |
| WO1995031183A1 (en) * | 1994-05-16 | 1995-11-23 | Washington University | Cell membrane fusion composition and method |
| ES2212305T3 (es) * | 1997-06-23 | 2004-07-16 | Alza Corporation | Polinucleotidos encapsulados en liposomas, composicion y procedimiento. |
| JP3243508B2 (ja) * | 1999-09-10 | 2002-01-07 | 独立行政法人産業技術総合研究所 | 濃度測定方法 |
| US6673564B2 (en) * | 1999-10-18 | 2004-01-06 | Millennium Pharmaceuticals, Inc. | Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| WO2002014483A2 (en) * | 2000-08-15 | 2002-02-21 | Zymogenetics Inc | Human adenosine deaminase |
| WO2003068190A1 (en) * | 2002-02-13 | 2003-08-21 | Northeastern University | Intracellular delivery of therapeutic agents |
-
2002
- 2002-12-12 AU AU2002953285A patent/AU2002953285A0/en not_active Abandoned
-
2003
- 2003-12-04 AT AT03812529T patent/ATE358719T1/de not_active IP Right Cessation
- 2003-12-04 EP EP03812529A patent/EP1573001B1/de not_active Expired - Lifetime
- 2003-12-04 DE DE60313031T patent/DE60313031T2/de not_active Expired - Lifetime
- 2003-12-04 JP JP2004557650A patent/JP2006509501A/ja active Pending
- 2003-12-04 ES ES03812529T patent/ES2285271T3/es not_active Expired - Lifetime
- 2003-12-04 WO PCT/AU2003/001619 patent/WO2004053118A1/en not_active Ceased
- 2003-12-04 NZ NZ541173A patent/NZ541173A/en not_active IP Right Cessation
- 2003-12-11 US US10/734,721 patent/US20040147028A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1573001A1 (de) | 2005-09-14 |
| EP1573001B1 (de) | 2007-04-04 |
| DE60313031D1 (de) | 2007-05-16 |
| US20040147028A1 (en) | 2004-07-29 |
| AU2002953285A0 (en) | 2003-01-02 |
| NZ541173A (en) | 2008-07-31 |
| ES2285271T3 (es) | 2007-11-16 |
| EP1573001A4 (de) | 2005-11-16 |
| WO2004053118A1 (en) | 2004-06-24 |
| JP2006509501A (ja) | 2006-03-23 |
| DE60313031T2 (de) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008109031A8 (en) | Liposome carriers for in vivo delivery of fullerenes | |
| AU2002232788A1 (en) | Self forming, thermodynamically stable liposomes and their applications | |
| AU2192395A (en) | Novel cationic phospholipids for transfection | |
| AU2002302364A1 (en) | Amphoteric sterols and the use thereof in the production of pH-sensitive liposomes | |
| DE60313031D1 (de) | Hefebehandlung | |
| NO20003471L (no) | Fremstilling av en lipidblanding og en fosfolipidsuspensjon som inneholder lipidblandingen | |
| EA199900715A1 (ru) | Липидные комплексы и липосомы совершенно нерастворимых комплексов платины | |
| AU2002330273A1 (en) | Liposome-encapsulated insulin formulations | |
| AU2001237254A1 (en) | Lowering serum lipids | |
| KR950700725A (ko) | 리포솜 조성물(liposome composition) | |
| DK1135193T3 (da) | Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen | |
| IL179012A0 (en) | Method and composition for treating rhinitis | |
| NO983520L (no) | Fremgangsmåte for fremstilling av lysofosfatidylcholin | |
| AU2002348971A1 (en) | Ph-sensitive liposomes for targeted drug delivery | |
| HK1038513A1 (zh) | 糖苷少層狀小泡 | |
| WO2004037223A3 (de) | Liposomen formende zusammensetzung | |
| ATE419833T1 (de) | Modulares zielgerichtetes liposomales verabreichungssytem | |
| WO2004069224A3 (en) | Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs | |
| DE50208813D1 (en) | (ester)-lysolecithine in liposomen | |
| DE60117465D1 (de) | Lipide mit aminoxygruppe | |
| SE0303135D0 (sv) | Controlled food effect composition | |
| BR0313230A (pt) | Uso de carboxamidas para o tratamento de tinido | |
| AU2002342770A1 (en) | Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised | |
| AU2003276282A1 (en) | Arrangement in the on-line finisching of the paper machine | |
| AU3989295A (en) | Liposomal interferon hybrid compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |